Integrated Nano-Technologies Appoints Former U.S. Army Chief of Staff and World-Renowned Virologist to Its Advisory Board

May 12, 2004, 01:00 ET from Integrated Nano-Technologies

    ROCHESTER, N.Y., May 12 /PRNewswire/ -- Integrated Nano-Technologies
 (INT), developer of a highly sensitive, accurate, nano-scale bioelectronic DNA
 identification platform, has appointed General Dennis J. Reimer, former Chief
 of Staff of the U.S. Army, and Richard J. Whitley, MD, world-renowned
 virologist, to its advisory panel.  Both will play a substantial role in
 launching INT's innovative device, BioDetect(TM), which is now in the advanced
 testing stage.  The technology provides rapid biological agent identification
 for the biosecurity and clinical diagnostics markets.
     "We are very pleased to have these distinguished leaders joining us on our
 advisory board," said Dr. Michael Connolly, CEO of INT.  "Their expertise in
 biosecurity and virology will be instrumental as we continue to advance our
 technology for biological agent identification and other applications."
     General Reimer currently serves as Director of the National Memorial
 Institute for the Prevention of Terrorism (MIPT), whose mission is to "prevent
 and deter terrorism or mitigate the results."  MIPT's focus is on the
 emergency responder community across the nation and they have sponsored
 research projects on how better to detect and protect against chemical,
 biological, radiological, nuclear and high explosive threats.  Prior to being
 named Director of MIPT, Reimer served 37 years in the U.S. Army and was
 appointed the 33rd Chief of Staff, U.S. Army in 1995.  Among his many
 accomplishments during his military career, General Reimer served as
 Commanding General of the United States Army, Forces Command, Fort McPherson,
 Georgia and as Deputy Chief of Staff for Operations in Korea.  General
 Reimer's awards for peacetime and combat service include the Defense
 Distinguished Service Medal, the Distinguished Service Medal, two Legions of
 Merit, the Distinguished Flying Cross, six awards of the Bronze Star Medal,
 the Purple Heart and the Combat Infantryman Badge.
     Richard J. Whitley, MD, a world-renowned virologist, is currently involved
 in a federally funded scientific effort to study the diagnosis and treatment
 of potential biowarfare agents.  He is Professor of Pediatrics, Microbiology
 and Medicine; Chair in Pediatrics; and Director, Division of Pediatric
 Infectious Diseases at the University of Alabama at Birmingham.  Dr. Whitley
 has focused on developing and evaluating antiviral therapies for the treatment
 of encephalitis infections, and on the development of gene therapy approaches
 to antiviral and antitumor therapy.
     Dr. Whitley was honored with the Aventis Award by the American Society for
 Microbiology in 2000 and the International Society for Antiviral Research
 Award for distinguished scientific accomplishments in 1998. Dr. Whitley is
 presently an Editor of Antiviral Research, and is a member of the Editorial
 Boards of the Journal of Infectious Diseases, Sexually Transmitted Diseases,
 Reviews in MedicalVirology, Antimicrobial Agents and Chemotherapy, Antiviral
 Chemistry and Chemotherapy, Infectious Diseases Watch for Pediatricians,
 Seminars in Pediatric Infectious Diseases, Gene Therapy and Medscape
 Infectious Disease.
     About Integrated Nano-Technologies, LLC
     Rochester, NY-based Integrated Nano-Technologies, LLC is a leading
 innovator in highly accurate, sensitive, rapid, portable, electronic,
 biological agent identification technology.  Built around the BioDetect(TM)
 Platform, INT's devices are highly portable and use disposable test cards to
 test field samples for numerous biological agents, including anthrax, in as
 little as 20 minutes.  Future developments of the platform will enable the
 medical community to identify specific illness causing pathogens in patients
 without sending samples out to laboratories; facilitating faster and more
 accurate treatment regimens.  For more information about Integrated
 Nano-Technologies, call 585-334-0170 or visit their Web site at
     This press release contains forward-looking statements that are based upon
 our current expectations and speak only as of the date hereof. Our actual
 results may differ materially and adversely from those expressed in any
 forward-looking statements as a result of various factors and uncertainties,
 including our ability to successfully develop products, rapid technological
 change in our markets, changes in demand for our future products, legislative,
 regulatory and competitive developments and general economic conditions. We
 undertake no obligation to revise or update publicly any forward-looking
 statements for any reason.

SOURCE Integrated Nano-Technologies